Ronald Regino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ronald Regino has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Josefina Zakzuk
Institute for Immunological Research, University of Cartagena, Cartagena 130014, Colombia
6 shared publications - Luis Caraballo
Institute for Immunological Research, University of Cartagena, Cartagena 130014, Colombia
6 shared publications - Ines Benedetti
Department of Basic Sciences, School of Medicine, University of Cartagena, Cartagena 130014, Colombia
4 shared publications - Dilia Mercado
Institute for Immunological Research, University of Cartagena, Cartagena 130014, Colombia
3 shared publications - Karen Donado
Institute for Immunological Research, University of Cartagena, Cartagena 130014, Colombia
3 shared publications - Leonardo Puerta
Institute for Immunological Research, University of Cartagena, Cartagena 130014, Colombia
3 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (22) , 10070
Hybrid Protein Combining Blo t 5 and Der p 2 Allergens from House Dust Mite Shows Allergenic Activity and Diagnostic Potential
Der p 2 and Blo t 5 are main allergens from house dust mites and play central roles in IgE-mediated hypersensitivity. Hybrid allergen molecules represent a promising strategy for component-resolved diagnostics. This study aimed to characterize a recombinant hybrid molecule composed of full-length Der p 2 and Blo t 5 (BP-2) and to evaluate its allergenic activity. Allergenicity and IgE-binding activity of BP-2 were assessed in asthma patients. Immunogenicity was examined in BALB/c mice sensitized and challenged with BP-2, followed by quantification of specific immunoglobulins, histopathological evaluation of airway inflammation and goblet cell hyperplasia, and assessment of airway hyperresponsiveness via methacholine challenge. BP-2 exhibited strong IgE reactivity in asthma patients and effectively discriminated between asthma patients and healthy controls (AUC = 0.806, 95% CI: 0.764–0.844). Cross-inhibition assays demonstrated that BP-2 retains functional epitopes shared with Blo t 5, Der p 2, and allergen extracts. In the murine model, the humoral and cellular immune responses induced by BP-2 suggest a profile with a predominant role of the T2 component characterized by IL-4 and IL-17A production and specific antibody generation. BP-2 is a biologically active hybrid allergen capable of detecting dual sensitization to Dermatophagoides pteronyssinus and Blomia tropicalis, supporting its potential application in component-resolved diagnostics for mite allergy.
- 10 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (22) , 10070
Open AccessHybrid Protein Combining Blo t 5 and Der p 2 Allergens from House Dust Mite Shows Allergenic Activity and Diagnostic Potential
Der p 2 and Blo t 5 are main allergens from house dust mites and play central roles in IgE-mediated hypersensitivity. Hybrid allergen molecules represent a promising strategy for component-resolved diagnostics. This study aimed to characterize a recombinant hybrid molecule composed of full-length Der p 2 and Blo t 5 (BP-2) and to evaluate its allergenic activity. Allergenicity and IgE-binding activity of BP-2 were assessed in asthma patients. Immunogenicity was examined in BALB/c mice sensitized and challenged with BP-2, followed by quantification of specific immunoglobulins, histopathological evaluation of airway inflammation and goblet cell hyperplasia, and assessment of airway hyperresponsiveness via methacholine challenge. BP-2 exhibited strong IgE reactivity in asthma patients and effectively discriminated between asthma patients and healthy controls (AUC = 0.806, 95% CI: 0.764–0.844). Cross-inhibition assays demonstrated that BP-2 retains functional epitopes shared with Blo t 5, Der p 2, and allergen extracts. In the murine model, the humoral and cellular immune responses induced by BP-2 suggest a profile with a predominant role of the T2 component characterized by IL-4 and IL-17A production and specific antibody generation. BP-2 is a biologically active hybrid allergen capable of detecting dual sensitization to Dermatophagoides pteronyssinus and Blomia tropicalis, supporting its potential application in component-resolved diagnostics for mite allergy.
- Open Access
- 5 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10765
Der p 23, A Frequent IgE Sensitizer in Humans, Induces Airway Inflammation in Mice
Der p 23 induces a high-frequency sensitization in allergic individuals. However, its allergenic activity and clinical impact are scarce. We aimed to evaluate the ability of rDer p 23 to induce allergic inflammation in a mouse model and to test IgE reactivity in humans. Female Balb/c mice were sensitized and challenged with rDer p 23 and Dermatophagoides pteronyssinus extract. Specific antibodies were determined by ELISA, inflammatory cell infiltration and goblet cells hyperplasia were evaluated by lung histology, and bronchial hyperreactivity (BHR) was assessed by the FinePoint RC SystemTM and whole-body plethysmography (WBP). IgE reactivity was evaluated by ELISA, the basophils activation test (BAT) and the skin pick test (SPT) in humans. rDer p 23, produced in Escherichia coli, adopts a random coil structure, predominantly exists in a monomeric state, and exhibits high stability. rDer p 23-treated mice showed a significant increase in lung resistance and bronchial hyperreactivity, as well as in eosinophils, neutrophils, and T cell count in bronchoalveolar lavage fluid (BALF). Cytokine and antibodies profiles were biased to a Type-2 response. No significant difference was observed in group 2 Innate Lymphoid Cells (ILC-2s) in lung and regulatory T cells (Treg) in the spleen. In asthmatic individuals sensitized to D. pteronyssinus, serum IgE reactivity to rDer p 23 was 67.5%. BAT and SPT results were significantly higher in allergic patients. Our findings support the pro-allergenic role of rDer p 23 in the development of the pathological features of asthma.
- 5 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10765
Open AccessDer p 23, A Frequent IgE Sensitizer in Humans, Induces Airway Inflammation in Mice
Der p 23 induces a high-frequency sensitization in allergic individuals. However, its allergenic activity and clinical impact are scarce. We aimed to evaluate the ability of rDer p 23 to induce allergic inflammation in a mouse model and to test IgE reactivity in humans. Female Balb/c mice were sensitized and challenged with rDer p 23 and Dermatophagoides pteronyssinus extract. Specific antibodies were determined by ELISA, inflammatory cell infiltration and goblet cells hyperplasia were evaluated by lung histology, and bronchial hyperreactivity (BHR) was assessed by the FinePoint RC SystemTM and whole-body plethysmography (WBP). IgE reactivity was evaluated by ELISA, the basophils activation test (BAT) and the skin pick test (SPT) in humans. rDer p 23, produced in Escherichia coli, adopts a random coil structure, predominantly exists in a monomeric state, and exhibits high stability. rDer p 23-treated mice showed a significant increase in lung resistance and bronchial hyperreactivity, as well as in eosinophils, neutrophils, and T cell count in bronchoalveolar lavage fluid (BALF). Cytokine and antibodies profiles were biased to a Type-2 response. No significant difference was observed in group 2 Innate Lymphoid Cells (ILC-2s) in lung and regulatory T cells (Treg) in the spleen. In asthmatic individuals sensitized to D. pteronyssinus, serum IgE reactivity to rDer p 23 was 67.5%. BAT and SPT results were significantly higher in allergic patients. Our findings support the pro-allergenic role of rDer p 23 in the development of the pathological features of asthma.
- Open Access
Comparison of Antibody Responses against Two Molecules from Ascaris lumbricoides: The Allergen Asc l 5 and the Immunomodulatory Protein Al-CPI
Immunity to Ascaris lumbricoides influences the pathogenesis of allergic diseases. Antibody responses to its proteins have been found to be associated with asthma presentation; however, helminth products that induce immunosuppression have been reported, which also raise specific antibodies. We aimed to evaluate antibody responses (IgE, IgG4 and IgG) to two A. lumbricoides molecules, Asc l 5 and Al-CPI (an anti-inflammatory Cysteine Protease Inhibitor), in an endemic population, exploring their relationships with the infection and asthma. The two molecules were produced as recombinant proteins in E. coli expression systems. Specific antibodies were detected by ELISA. Lower human IgE, but higher IgG4 and IgG antibody levels were observed for Al-CPI than for rAsc l 5. The IgE/IgG4 isotype ratio was significantly higher for Asc l 5 than for Al-CPI. In humans Al-CPI did not induce basophil activation as has been previously described for Asc l 5. In mice, Al-CPI induced fewer IgE responses, but more IgG2a antibody titers than rAsc l 5. Our results suggest that these molecules elicit different patterns of immune response to A. lumbricoides.
Open AccessComparison of Antibody Responses against Two Molecules from Ascaris lumbricoides: The Allergen Asc l 5 and the Immunomodulatory Protein Al-CPI
Immunity to Ascaris lumbricoides influences the pathogenesis of allergic diseases. Antibody responses to its proteins have been found to be associated with asthma presentation; however, helminth products that induce immunosuppression have been reported, which also raise specific antibodies. We aimed to evaluate antibody responses (IgE, IgG4 and IgG) to two A. lumbricoides molecules, Asc l 5 and Al-CPI (an anti-inflammatory Cysteine Protease Inhibitor), in an endemic population, exploring their relationships with the infection and asthma. The two molecules were produced as recombinant proteins in E. coli expression systems. Specific antibodies were detected by ELISA. Lower human IgE, but higher IgG4 and IgG antibody levels were observed for Al-CPI than for rAsc l 5. The IgE/IgG4 isotype ratio was significantly higher for Asc l 5 than for Al-CPI. In humans Al-CPI did not induce basophil activation as has been previously described for Asc l 5. In mice, Al-CPI induced fewer IgE responses, but more IgG2a antibody titers than rAsc l 5. Our results suggest that these molecules elicit different patterns of immune response to A. lumbricoides.
- Open Access
- 14 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (6) , 5543
The Allergenic Activity of Blo t 2, a Blomia tropicalis IgE-Binding Molecule
Only few allergens derived from house dust mite (HDM) species have been evaluated in terms of their potential to induce allergic inflammation. In this study, we aimed to evaluate different aspects of the allergenicity and allergenic activity of Blo t 2, a Blomia tropicalis allergen. Blo t 2 was produced as a recombinant protein in Escherichia coli. Its allergenic activity was tested in humans by skin prick test and basophil activation assays, and in mice, by passive cutaneous anaphylaxis and a model of allergic airway inflammation. Sensitization rate to Blo t 2 (54.3%) was similar to that found to Blo t 21 (57.2%) and higher than to Der p 2 (37.5%). Most Blo t 2-sensitized patients showed a low intensity response (99.5%). Blo t 2 elicited CD203c upregulation and allergen induced skin inflammation. Additionally, immunized animals produced anti-Blo t 2 IgE antibodies and passive transfer of their serum to non-immunized animals induced skin inflammation after allergen exposure. Immunized animals developed bronchial hyperreactivity and a strong inflammatory lung reaction (eosinophils and neutrophils). These results confirm the allergenic activity of Blo t 2 and supports its clinical relevance.
- 14 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (6) , 5543
Open AccessThe Allergenic Activity of Blo t 2, a Blomia tropicalis IgE-Binding Molecule
Only few allergens derived from house dust mite (HDM) species have been evaluated in terms of their potential to induce allergic inflammation. In this study, we aimed to evaluate different aspects of the allergenicity and allergenic activity of Blo t 2, a Blomia tropicalis allergen. Blo t 2 was produced as a recombinant protein in Escherichia coli. Its allergenic activity was tested in humans by skin prick test and basophil activation assays, and in mice, by passive cutaneous anaphylaxis and a model of allergic airway inflammation. Sensitization rate to Blo t 2 (54.3%) was similar to that found to Blo t 21 (57.2%) and higher than to Der p 2 (37.5%). Most Blo t 2-sensitized patients showed a low intensity response (99.5%). Blo t 2 elicited CD203c upregulation and allergen induced skin inflammation. Additionally, immunized animals produced anti-Blo t 2 IgE antibodies and passive transfer of their serum to non-immunized animals induced skin inflammation after allergen exposure. Immunized animals developed bronchial hyperreactivity and a strong inflammatory lung reaction (eosinophils and neutrophils). These results confirm the allergenic activity of Blo t 2 and supports its clinical relevance.
- Open Access
- 21 December 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (24) , 9761
Identification and Physicochemical Characterization of a New Allergen from Ascaris lumbricoides
To analyze the impact of Ascaris lumbricoides infection on the pathogenesis and diagnosis of allergic diseases, new allergens should be identified. We report the identification of a new Ascaris lumbricoides allergen, Asc l 5. The aim of this study was to evaluate the physicochemical and immunological features of the Asc l 5 allergen. We constructed an A. lumbricoides cDNA library and Asc l 5 was identified by immunoscreening. After purification, rAsc l 5 was physicochemically characterized. Evaluation of its allergenic activity included determination of Immunoglobulin E (IgE) binding frequency (in two populations: 254 children and 298 all-age subjects), CD203c based-basophil activation tests (BAT) and a passive cutaneous anaphylaxis (PCA) mouse model. We found by amino acid sequence analysis that Asc l 5 belongs to the SXP/RAL-2 protein family of nematodes. rAsc l 5 is a monomeric protein with an alpha-helical folding. IgE sensitization to rAsc l 5 was around 52% in general population; positive BAT rate was 60%. rAsc l 5 induced specific IgE production in mice and a positive PCA reaction. These results show that Asc l 5 has structural and immunological characteristics to be considered as a new allergen from A. lumbricoides.
- 21 December 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (24) , 9761
Open AccessIdentification and Physicochemical Characterization of a New Allergen from Ascaris lumbricoides
To analyze the impact of Ascaris lumbricoides infection on the pathogenesis and diagnosis of allergic diseases, new allergens should be identified. We report the identification of a new Ascaris lumbricoides allergen, Asc l 5. The aim of this study was to evaluate the physicochemical and immunological features of the Asc l 5 allergen. We constructed an A. lumbricoides cDNA library and Asc l 5 was identified by immunoscreening. After purification, rAsc l 5 was physicochemically characterized. Evaluation of its allergenic activity included determination of Immunoglobulin E (IgE) binding frequency (in two populations: 254 children and 298 all-age subjects), CD203c based-basophil activation tests (BAT) and a passive cutaneous anaphylaxis (PCA) mouse model. We found by amino acid sequence analysis that Asc l 5 belongs to the SXP/RAL-2 protein family of nematodes. rAsc l 5 is a monomeric protein with an alpha-helical folding. IgE sensitization to rAsc l 5 was around 52% in general population; positive BAT rate was 60%. rAsc l 5 induced specific IgE production in mice and a positive PCA reaction. These results show that Asc l 5 has structural and immunological characteristics to be considered as a new allergen from A. lumbricoides.
- Open Access
- 1 February 2019
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 143 (2) , AB187
Evaluation of the allergenic activity of the Glutathione Transferase from Blomia tropicalis (Blo t 8) in a mouse model of airway inflammation
- 1 February 2019
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 143 (2) , AB187
Open AccessEvaluation of the allergenic activity of the Glutathione Transferase from Blomia tropicalis (Blo t 8) in a mouse model of airway inflammation